Home / Resources / APAC on the Rise

APAC on the Rise

Infographic
Clinical
''
''

Last updated: Feb 4, 2026


The Asia-Pacific (APAC) region has emerged as a leader in the global clinical trial landscape amid a significant increase in clinical trials and growing international recognition. Several key factors have driven this shift, including a diverse and substantial patient population, cost effectiveness in conducting clinical trials, and a favorable regulatory environment.


Download
Related products
Professional using a laptop device to access Trialtrove for trial insights and strategy.
Trialtrove
Discover the ultimate clinical trial benchmarking tool

Related resources

A close-up of a doctor's hands touching a pill.
NOV 03, 2023
White paper
Clinical

The Annual Clinical Trials Roundup

This report focuses on an overview of Phase I–III clinical trials that initiated in 2022 across all therapeutic areas.

A group of scientists in lab coats studies samples in a laboratory with graphs displayed in the background.
OCT 02, 2024
White paper
Clinical

The Annual Clinical Trials Roundup 2024 Edition: Promising Road to Recovery

The 2024 Clinical Trials Round focuses on Phase I–III clinical trials that initiated in 2023 across all therapeutic areas covered by Citeline’s Trialtrove.

Exploring the Asia-Pacific Clinical Trials Landscape: Asking the Five W’s
OCT 10, 2024
White paper
Clinical

Exploring the Asia-Pacific Clinical Trials Landscape: Asking the Five W’s

Citeline’s analysis delves into the Asia-Pacific clinical trial landscape from 2019 to 2023, drawing insights from our Trialtrove platform.

View all